A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
|Slideshows|October 1, 2022
Antivirals Recommended for Influenza Treatment & Chemoprophylaxis: Basics, Notes, Cautions
Author(s)Grace Halsey
This influenza antiviral brush-up slide show reminds you of key features of the 4 FDA-recommended medications, at-a-glance.
Advertisement
Antiviral medications against
There are 4 FDA-recommended drugs available as treatment for or prophylaxis against the flu: the neuraminidase inhibitors oral oseltamivir (Tamiflu®), inhaled zanamivir (Relenza®), and intravenous peramivir (Rapivab®), and the cap-dependent endonuclease inhibitor baloxavir marboxil (Xofluza®).
Even if your familiar with all of them, click through this quick slide show based on the Centers for Disease Control and Prevention summary for clinicians on
Advertisement
Related to this article
FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
3
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
4
Lyme Seropositivity Linked to Tick-Borne Co-Exposure in US Laboratory Study
5